AEye Will Not Attend CES 2022 in Person out of Concern for the Health and Safety of Employees, Partners, and Customers
Company Will Webcast “Live with AEye: Virtual CES 2022” Featuring Demos, Videos, and Interviews with…
Company Will Webcast “Live with AEye: Virtual CES 2022” Featuring Demos, Videos, and Interviews with…
Vancouver, British Columbia–(Newsfile Corp. – December 30, 2021) – Neptune Digital Assets Corp. (TSXV: NDA)…
Singapore, Singapore–(Newsfile Corp. – December 30, 2021) – Zecrey Protocol, a ZK-rollup-based layer 2 privacy…
Industry experts CTO Jason Rudolph, CMO Kathy Bryan & Director of Social Media Lauren Konopelski…
LA MIRADA, CA / ACCESSWIRE / December 30, 2021 / While improving tax compliance has…
EDMONTON, AB / ACCESSWIRE / December 30, 2021 / OneSoft Solutions Inc. (the “Company” or…
CORONA, CA / ACCESSWIRE / December 30, 2021 / Envirotech Vehicles, Inc. (OTCQB:EVTV), a provider…
CORONA, CA / ACCESSWIRE / December 30, 2021 / Envirotech Vehicles, Inc. (OTCQX:EVTV), a provider…
Fati Hakim overseeing internal and external operational related activities including ongoing Group projects. SINGAPORE /…
More avenues for investors to lend, borrow and swap and bridge their assets seamlessly within…
Independent Certification Enables the Company to Produce for Major Retailers Worldwide HICKSVILLE, NY / ACCESSWIRE…
Screened approximately 700 subjects and expanding to Eastern Europe, including Turkey, as part of its…
CARLSBAD, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage…
REDWOOD CITY, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life…
Ewing sarcoma arm advances to second lead-in safety dosing cohort in Sarcoma trial evaluating seclidemstat…
Ji’an, Jiangxi, China, Dec. 29, 2021 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
SEATTLE, Dec. 29, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial…
WATERTOWN, Mass., Dec. 29, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
Company developing STAT-201 as a novel therapy for immune modulation in treating pediatric patients with…
— H.C. Wainwright BIOCONNECT Virtual Conference — — 11th Annual LifeSci Partners Corporate Access Event —…